{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:58:15Z","timestamp":1774418295276,"version":"3.50.1"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.anndiagpath.2019.151407","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:20:01Z","timestamp":1567538401000},"page":"151407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Core needle biopsy of benign, borderline and in-situ problematic lesions of the breast: Diagnosis, differential diagnosis and immunohistochemistry"],"prefix":"10.1016","volume":"43","author":[{"given":"Marilin","family":"Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Agosto-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PAP.0b013e31821698cc","article-title":"Borderline breast lesions: diagnostic challenges and clinical implications","volume":"18","author":"Masood","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0010","doi-asserted-by":"crossref","unstructured":"Elmore JG, Longton GM, Carney PA, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015.17;313(11):1122\u20131132.","DOI":"10.1001\/jama.2015.1405"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jnci\/djhs105","article-title":"Lower category benign breast disease and the risk of invasive breast cancer","volume":"96","author":"Wang","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00666428","article-title":"Anatomic indicators (histologic and cytologic) of increased breast cancer risk","volume":"28","author":"Page","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2010.56","article-title":"Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology","volume":"23","author":"Ellis","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast Cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0040","series-title":"Rosen\u2019s breast pathology","first-page":"95","author":"Hoda","year":"2014"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0045","series-title":"World Health Organization classification of tumours of the breast","first-page":"43","author":"Lakhani","year":"2012"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0046-8177(95)90273-2","article-title":"Comparative morphometric studies of benign and malignant intraductal proliferative lesions of the breast by computerized image analysis","volume":"26","author":"Ozaki","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0055","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO;2-P","article-title":"Anatomic markers of human premalignancy and risk of breast cancer","volume":"66","author":"Page","year":"1990","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10549-014-2862-5","article-title":"Sclerosing adenosis and risk of breast cancer","volume":"144","author":"Visscher","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0065","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0046-8177(92)90026-Y","article-title":"Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia","volume":"23","author":"Page","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1245\/s10434-016-5512-9","article-title":"Long-term safety of observation in selected women following core biopsy diagnosis of atypical ductal hyperplasia","volume":"24","author":"Menen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0075","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression","volume":"100","author":"Ma","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/bcr623","article-title":"The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) \u2014 current definitions and classification","volume":"5","author":"Pinder","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1309\/61HM-89TD-0M3L-JAHH","article-title":"Atypical ductal hyperplasia in breast core needle biopsies correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies","volume":"116","author":"Renshaw","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoncol.2016.3022","article-title":"Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy","volume":"3","author":"Menes","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1148\/radiology.179.3.2027988","article-title":"Atypical hyperplasia of the breast: mammographic appearance and histologic correlation","volume":"179","author":"Helvie","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1148\/radiology.193.1.8090927","article-title":"Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia","volume":"193","author":"Jackman","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0105","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2214\/ajr.164.5.7717215","article-title":"Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy","volume":"164","author":"Liberman","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1066896916662154","article-title":"Atypical ductal hyperplasia bordering on ductal carcinoma in situ: interobserver variability and outcomes in 105 cases","volume":"25","author":"Tozbikian","year":"2017","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O","article-title":"A comparison of the results of long-term follow-up for atypical intraductal carcinoma of the breast","volume":"65","author":"Tavassoli","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I","article-title":"Breast cancer risk associated with proliferative breast disease and atypical hyperplasia","volume":"71","author":"Dupond","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/107327481702400117","article-title":"Differential gene expression in ductal carcinoma in situ of the breast based on ERBB2 status","volume":"24","author":"Agosto-Arroyo","year":"2017","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjc.6606021","article-title":"Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease","volume":"104","author":"Clark","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.pathol.4.110807.092306","article-title":"Preinvasive breast cancer","volume":"5","author":"Sgroi","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2019.151407_bb0140","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3816\/CBC.2007.n.026","article-title":"Ductal carcinoma in situ: biology, diagnosis, and new therapies","volume":"7","author":"Valenzuela","year":"2007","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/djp485","article-title":"National Institutes of Health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009","volume":"102","author":"Allegra","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0150","first-page":"225","article-title":"Cancer statistics","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0155","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archsurg.1992.01420120026004","article-title":"Ten-year follow-up of breast carcinoma in situ in Connecticut","volume":"127","author":"Ward","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0160","first-page":"220","article-title":"In situ ductal carcinoma of the breast\u2014analysis of clinical presentation and outcome in 156 consecutive cases","volume":"16","author":"Ciatto","year":"1990","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1148\/radiology.190.2.8284404","article-title":"Suspicious breast lesions: MR imaging with radiologic\u2013pathologic correlation","volume":"190","author":"Orel","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004424-199401000-00019","article-title":"Contrast-enhanced magnetic resonance imaging of the breast","volume":"29","author":"Heywang-K\u00f6brunner","year":"1994","journal-title":"Invest Radiol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/030089169007600607","article-title":"Intraductal breast carcinoma. Review of a multicenter series of 350 cases","volume":"76","author":"Ciatto","year":"1990","journal-title":"Tumori"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2559.1999.035005393.x","article-title":"DCIS grading schemes and clinical implications","volume":"35","author":"Shoker","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0185","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1798::AID-CNCR15>3.0.CO;2-0","article-title":"Consensus conference on the classification of ductal carcinoma in situ","volume":"80","author":"The Consensus Conference Committee","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00000478-198006000-00004","article-title":"Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit","volume":"4","author":"Rosen","year":"1980","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.151407_bb0195","first-page":"686","article-title":"Estrogen receptor and cytokeratin 5 are reliable markers to separate usual ductal hyperplasia from atypical ductal hyperplasia and low-grade ductal carcinoma in situ","volume":"140","author":"Martinez","year":"2016","journal-title":"Arch Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0200","first-page":"220","article-title":"Use of immunohistochemical stains in epithelial lesions of the breast","volume":"22","author":"Khazai","year":"2015","journal-title":"Cancer Contrl"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0205","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2559.2000.00882.x","article-title":"Cytokeratin 5\/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast","volume":"37","author":"Otterbach","year":"2000","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1066896908316901","article-title":"The role of cytokeratin 5\/6 as an adjunct diagnostic tool in breast core needle biopsies","volume":"16","author":"Nofech-Mozes","year":"2008","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151407_bb0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/jclinpath-2012-201109","article-title":"Use of immunohistochemistry in the diagnosis of problematic breast lesions","volume":"66","author":"Lee","year":"2013","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11596-006-0406-x","article-title":"The value of p63 and CK5\/6 expression in the differential diagnosis of ductal lesions of breast","volume":"26","author":"Ding","year":"2006","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00125480-200205000-00002","article-title":"Molecular and biologic markers of premalignant lesions of human breast","volume":"9","author":"Krishnamurthy","year":"2002","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0230","first-page":"127","article-title":"Expression of cytokeratin markers, ER-alpha, PR, HER-2\/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast","volume":"37","author":"Steinman","year":"2007","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8","article-title":"Oestrogen receptor expression in the normal and pre-cancerous breast","volume":"188","author":"Shoker","year":"1999","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PAS.0b013e318161d1a5","article-title":"Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family","volume":"32","author":"Abdel-Fatah","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0245","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0046-8177(90)90154-W","article-title":"Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ","volume":"21","author":"Bartkova","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0250","first-page":"257","article-title":"Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression","volume":"7","author":"Poller","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0255","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/modpathol.3800658","article-title":"Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers","volume":"19","author":"Raban","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0260","first-page":"153","article-title":"Adenoic cystic carcinoma of the breast: a histologic, cytologic, and immunohistochemical study","volume":"6","author":"Lamovec","year":"1989","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0265","series-title":"Tumors of the mammary gland. AFIP atlas of tumors pathology","author":"Tavassoli","year":"2009"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0270","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.prp.2012.05.002","article-title":"CD10 and HHF35 actin in the differential diagnosis between collagenous spherulosis and adenoid cystic carcinoma of the breast","volume":"208","author":"Cabibi","year":"2012","journal-title":"Pathol Res Pract"},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.151407_bb0275","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.prp.2010.02.010","article-title":"Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall","volume":"206","author":"Rosa","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0280","first-page":"1053","article-title":"Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American pathologists","volume":"122","author":"Fitzgibbons","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151407_bb0285","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-143-6-200509200-00009","article-title":"Premalignant and in situ breast disease: biology and clinical implications","volume":"143","author":"Arpino","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0290","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/cncr.22136","article-title":"The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses\u2019 Health Study","volume":"107","author":"Collins","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151407_bb0295","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00000478-200306000-00017","article-title":"Benign breast disease and breast cancer risk: morphology and beyond","volume":"27","author":"Schnitt","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0300","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1245\/s10434-012-2575-0","article-title":"Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?","volume":"19","author":"McGhan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0305","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.amjsurg.2006.06.003","article-title":"Correlation between core biopsy and excisional biopsy in breast high-risk lesions","volume":"192","author":"Margenthaler","year":"2006","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0310","first-page":"307","article-title":"The molecular pathology of breast cancer progression","volume":"233","author":"Bombonati","year":"2011","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157339412802653182","article-title":"Molecular pathology and molecular markers of ductal carcinoma in-situ","volume":"8","author":"Wolff","year":"2012","journal-title":"Curr Cancer Ther Rev"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0320","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0325","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.anndiagpath.2019.151407_bb0330","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1002\/cncr.25942","article-title":"Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone","volume":"117","author":"Holmes","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151407_bb0335","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jso.21973","article-title":"The significance of HER-2\/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease","volume":"104","author":"Harada","year":"2011","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151407_bb0340","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/1055-9965.EPI-08-1101","article-title":"HER-2\/neu overexpression as a predictor for the transition from in situ to invasive breast cancer","volume":"18","author":"Roses","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0345","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fischer","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/cco.2017.02.02","article-title":"Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)","volume":"6","author":"Rastogi","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0355","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fischer","year":"1999","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.anndiagpath.2019.151407_bb0360","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1245\/s10434-015-4773-z","article-title":"An international multicenter review of the malignancy rate of excised papillomatous breast lesions","volume":"22","author":"Foley","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0365","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2214\/ajr.179.5.1791185","article-title":"Imaging-guided core needle biopsy of papillary lesions of breast","volume":"179","author":"Rosen","year":"2002","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0370","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiology.181.3.1947092","article-title":"Benign papillary neoplasms of the breast: mammographic findings","volume":"181","author":"Cardenosa","year":"1991","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0375","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1075-122X.2006.00248.x","article-title":"Papillary lesions of the breast","volume":"12","author":"Ibarra","year":"2006","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0380","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2214\/AJR.11.7922","article-title":"Papillary lesions of the breast: MRI, ultrasound, and mammographic appearances","volume":"198","author":"Eiada","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"10.1016\/j.anndiagpath.2019.151407_bb0385","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1245\/s10434-013-3191-3","article-title":"Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?","volume":"20","author":"Shamonki","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.151407_bb0390","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5858\/arpa.2016-0219-RA","article-title":"Papillary lesions of the breast: a practical approach to diagnosis","volume":"140","author":"Jorns","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0395","series-title":"Breast pathology diagnosis by needle core biopsy","first-page":"171","author":"Rosen","year":"2010"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0400","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V","article-title":"Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma","volume":"78","author":"Page","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0405","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PAP.0b013e318032508d","article-title":"Papillary lesions of the breast: a review","volume":"14","author":"Mulligan","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0410","series-title":"Pathology of the breast","article-title":"Papillary lesions","author":"Tavassoli","year":"1999"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0415","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2007.02898.x","article-title":"Papillary lesions of the breast: selected diagnostic and management issues","volume":"52","author":"Collins","year":"2008","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151407_bb0420","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/his.12463","article-title":"Papillary and neuroendocrine breast lesions: the WHO stance","volume":"66","author":"Tan","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0425","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00000478-200608000-00011","article-title":"Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers","volume":"30","author":"Collins","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0430","first-page":"36","article-title":"Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas","volume":"123","author":"Hill","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.151407_bb0435","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.5858\/arpa.2011-0227-RS","article-title":"Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor","volume":"136","author":"Saremian","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.151407_bb0440","doi-asserted-by":"crossref","first-page":"770","DOI":"10.5858\/arpa.2015-0525-RA","article-title":"Practical considerations in breast papillary lesions: a review of the literature","volume":"140","author":"Agoumi","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0445","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1148\/radiol.2421031988","article-title":"Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy","volume":"242","author":"Sydnor","year":"2007","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejso.2008.06.004","article-title":"The management of papillary lesion of the breast by core needle biopsy","volume":"35","author":"Tseng","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0455","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4048\/jbc.2016.19.4.410","article-title":"Predictive factors for upgrading patients with benign breast papillary lesions using a core needle biopsy","volume":"19","author":"Hong","year":"2016","journal-title":"J Breast Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0460","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pathol.2016.12.346","article-title":"The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service","volume":"49","author":"Armes","year":"2017","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0465","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjsurg.2006.11.028","article-title":"Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions","volume":"194","author":"Ashkenazi","year":"2007","journal-title":"Am J Surg"},{"issue":"13","key":"10.1016\/j.anndiagpath.2019.151407_bb0470","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/cncr.24321","article-title":"Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy","volume":"115","author":"Jaffer","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1148\/radiology.205.1.9314986","article-title":"Evaluation of 14- and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model","volume":"205","author":"Berg","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0480","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2559.2005.02082.x","article-title":"Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast","volume":"46","author":"Gardner","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0485","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2214\/ajr.175.5.1751341","article-title":"Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision","volume":"175","author":"Darling","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0490","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jamcollsurg.2005.02.025","article-title":"Ultrasound-guided, vacuum- assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia","volume":"201","author":"Grady","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0495","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2214\/ajr.177.2.1770405","article-title":"Sonographically guided directional vacuum-assisted breast biopsy using a handheld device","volume":"177","author":"Parker","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-006-9305-x","article-title":"Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases","volume":"102","author":"Cassano","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jcp.2006.037069","article-title":"Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy","volume":"60","author":"Douglas-Jones","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0510","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ejso.2004.08.004","article-title":"Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland","volume":"30","author":"Patterson","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0515","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jcp.56.10.721","article-title":"Pathology and clinical relevance of radial scars: a review","volume":"56","author":"Kennedy","year":"2003","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0520","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.mayocp.2014.02.004","article-title":"Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy","volume":"89","author":"Neal","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0525","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0009-9260(05)81239-5","article-title":"Complex sclerosing lesions (radial scars) of the breast can be palpable","volume":"48","author":"Wallis","year":"1993","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151407_bb0530","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2559.2007.02660.x","article-title":"Radial scars\/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited","volume":"50","author":"Doyle","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0535","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM199902113400604","article-title":"Radial scars in benign breast biopsy specimens and the risk of breast cancer","volume":"340","author":"Jacobs","year":"1999","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.anndiagpath.2019.151407_bb0540","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.MP.0000085027.75201.B5","article-title":"Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas","volume":"16","author":"Gobbi","year":"2003","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2019.151407_bb0545","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.5858\/arpa.2014-0496-OA","article-title":"Keratin expression patterns in stromal cells of benign sclerosing lesions of the breast: a potential diagnostic pitfall","volume":"139","author":"Oh","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0550","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0b013e3181dd60d3","article-title":"Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast","volume":"34","author":"Hilson","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0555","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0b013e318180431d","article-title":"Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications","volume":"33","author":"Hilson","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0560","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jclinpath-2011-200377","article-title":"Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions","volume":"65","author":"Chia","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0565","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-007-9569-9","article-title":"Risk of neoplastic transformation in asymptomatic radial scar: analysis of 117 cases","volume":"107","author":"Manfrin","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0570","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2214\/AJR.11.7717","article-title":"Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy","volume":"198","author":"Georgian-Smith","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151407_bb0575","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.amjsurg.2011.06.052","article-title":"Current management practice of breast borderline lesions\u2014need for further research and guidelines","volume":"203","author":"Nizri","year":"2012","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0580","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.anndiagpath.2014.12.003","article-title":"Radial scar\/complex sclerosing lesions: a clinicopathologic correlation study from a single institution","volume":"19","author":"Nassar","year":"2015","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0585","first-page":"3","article-title":"The radial scar of the breast diagnosed at core needle biopsy","volume":"25","author":"Morgan","year":"2012","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0590","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s40064-016-1993-z","article-title":"Isolated radial scar diagnosis by core-needle biopsy: is surgical excision necessary?","volume":"5","author":"Kim","year":"2016","journal-title":"Springerplus"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0595","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/COC.0b013e3182354a3f","article-title":"Rationale of excisional biopsy after the diagnosis of benign radial scar on core biopsy: a single institutional outcome analysis","volume":"36","author":"Andacoglu","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2019.151407_bb0600","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.5858\/arpa.2014-0550-OA","article-title":"Advocating nonsurgical management of patients with small, incidental radial scars at the time of needle core biopsy: a study of 77 cases","volume":"139","author":"Matrai","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0605","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2214\/ajr.179.5.1791179","article-title":"Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?","volume":"179","author":"Brenner","year":"2002","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0610","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10549-008-0119-x","article-title":"Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years\u2019 of experience at a single institution","volume":"127","author":"Resetkova","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0615","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00428-015-1769-9","article-title":"Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity","volume":"467","author":"Oiwa","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0620","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1524-4741.2003.09324.x","article-title":"Adenosis tumor of the breast","volume":"9","author":"Markopoulos","year":"2003","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0625","series-title":"Pathology of the breast","first-page":"32","article-title":"General considerations, benign lesions","author":"Tavassoli","year":"1999"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0630","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3892\/mco.2016.1108","article-title":"Sclerosing adenosis: ultrasonographic and mammographic findings and correlation with histopathology","volume":"6","author":"Chen","year":"2017","journal-title":"Mol Clin Onc"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0635","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4048\/jbc.2015.18.2.187","article-title":"Magnetic resonance imaging features of adenosis in the breast","volume":"18","author":"Gity","year":"2015","journal-title":"J Breast Canc"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0640","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/1097-0142(196712)20:12<2245::AID-CNCR2820201227>3.0.CO;2-0","article-title":"Epithelial invasion of nerves in benign diseases of the breast","volume":"20","author":"Taylor","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0645","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/path.1711090307","article-title":"Neural invasion in benign mammary dysplasia","author":"Davies","year":"1973","journal-title":"J Pathol"},{"issue":"49","key":"10.1016\/j.anndiagpath.2019.151407_bb0650","first-page":"1","article-title":"Breast sclerosing adenosis and accompanying malignancies","volume":"94","author":"Huang","year":"2015","journal-title":"Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0655","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1097-0142(19891115)64:10<1977::AID-CNCR2820641002>3.0.CO;2-N","article-title":"Invasive breast cancer risk in women with sclerosing adenosis","volume":"64","author":"Jensen","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0660","first-page":"31","article-title":"Noninvasive carcinoma of the breast pre-senting in adenosis","volume":"4","author":"Oberman","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0665","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1365-2559.1987.tb01871.x","article-title":"Adenosis tumour of the breast\u2014a clinicopathological in-vestigation of 27 cases","volume":"11","author":"Nielsen","year":"1987","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0670","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prp.2008.11.010","article-title":"The challenge of apocrine proliferation of the breast: a morphologic approach","volume":"205","author":"Masood","year":"2009","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0675","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.5858\/arpa.2016-0238-RA","article-title":"Atypical apocrine adenosis","volume":"140","author":"Asirvatham","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb0680","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00125480-199705000-00001","article-title":"Apocrine differentiation in breast epithelium","volume":"4","author":"Eusebi","year":"1997","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.151407_bb0685","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2529::AID-CNCR16>3.0.CO;2-U","article-title":"Atypical apocrine adenosis of the breast; a clinicopathological study of 37 patients with 8.7 year follow up","volume":"77","author":"Seidman","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0690","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2214\/ajr.180.3.1800795","article-title":"Mammographic-pathologic correlation of apocrine metaplasia diagnosed using vacuum-assisted stereotactic core-needle biopsy: our 4-year experience","volume":"180","author":"Kushwaha","year":"2003","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0695","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5858\/arpa.2011-0225-OA","article-title":"Atypical apocrine adenosis of the breast: long term follow-up in 37 patients","volume":"136","author":"Fuehrer","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.151407_bb0700","first-page":"1393","article-title":"Apocrine carcinoma of the breast: a comprehensive review","volume":"28","author":"Vranic","year":"2013","journal-title":"Histol Histopathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.151407_bb0705","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/jcp.2006.040626","article-title":"Non-operative breast pathology: apocrine lesions","volume":"60","author":"Wells","year":"2007","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.151407_bb0710","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.5858\/133.11.1817","article-title":"Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case","volume":"133","author":"Visscher","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0715","first-page":"1","article-title":"Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients","volume":"4","author":"Carter","year":"1991","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0720","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0b013e31820598a2","article-title":"Diminished number or complete loss of myoepithelial cell associated with metaplastic and neoplastic apocrine lesions of the breast","volume":"35","author":"Tramm","year":"2011","journal-title":"Am J Sur Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0725","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/PAS.0b013e31818af361","article-title":"Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma","volume":"33","author":"Shin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0730","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000478-198604000-00002","article-title":"Is microglandular adenosis a precancerous disease? A study of carcinoma arising therein","volume":"10","author":"Rosenblum","year":"1986","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0735","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.4726","article-title":"Microglandular adenosis: a prime suspect in triple-negative breast cancer development","volume":"239","author":"Tsang","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0740","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0b013e31815a87e2","article-title":"Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma","volume":"32","author":"Khalifeh","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0745","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAT.0b013e32834864f4","article-title":"Microglandular adenosis with transition to breast carcinoma: a series of three cases","volume":"43","author":"Lin","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0750","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000478-199302000-00001","article-title":"Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison","volume":"17","author":"Eusebi","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0755","first-page":"209","article-title":"Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast","volume":"3","author":"Prasad","year":"1998","journal-title":"Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0760","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0046-8177(92)90321-S","article-title":"Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation","volume":"23","author":"Eubesi","year":"1992","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151407_bb0765","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033728","article-title":"Apocrine differentiation in invasive pleomorphic lobular carcinoma with in situ ductal and lobular apocrine carcinoma: a case report","volume":"8","author":"Kaya","year":"2002","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.151407_bb0770","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.5858\/arpa.2012-0603-RS","article-title":"Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma","volume":"137","author":"Butler","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0775","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4048\/jbc.2011.14.1.72","article-title":"Microglandular adenosis","volume":"14","author":"Kim","year":"2011","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0780","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.2281020447","article-title":"When is a diagnosis of sclerosing adenosis acceptable at core biopsy?","volume":"228","author":"Gill","year":"2003","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0785","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0046-8177(87)80169-7","article-title":"Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breast","volume":"18","author":"Wellings","year":"1987","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0790","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.1711150405","article-title":"Apocrine metaplasia in cystic hyperplastic mastopathy: histochemical and ultra-structural observations","volume":"115","author":"Ahmed","year":"1975","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.151407_bb0795","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.humpath.2014.06.010","article-title":"Atypical apocrine adenosis diagnosed on core biopsy: implications for management","volume":"45","author":"Calhoun","year":"2014","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0800","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/modpathol.2016.161","article-title":"Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provided evidence of existence of a low-grade triple-negative breast neoplasia family","volume":"30","author":"Geyer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0805","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000478-198303000-00003","article-title":"Microglandular adenosis. A benign lesion simulating invasive mammary carcinoma","volume":"7","author":"Rosen","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0810","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/106689690000800409","article-title":"Carcinoma arising in microglandular adenosis: an Immunohistochemical analysis of 20 intraepithelial and invasive neoplasms","volume":"8","author":"Koenig","year":"2000","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0815","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2559.2009.03432.x","article-title":"Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma","volume":"55","author":"Geyer","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0820","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1111\/j.1365-2559.2012.04207.x","article-title":"Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis","volume":"60","author":"Geyer","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0825","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.4691","article-title":"Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations","volume":"238","author":"Guerini-Rocco","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0830","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5858\/2003-127-77-TYFUOM","article-title":"Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation","volume":"127","author":"Resetkova","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0835","first-page":"16","article-title":"Fibroadenoma of the breast: a clinical and pathological study","volume":"33","author":"Foster","year":"1988","journal-title":"J R Coll Surg Edinb"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0840","first-page":"1","article-title":"Fibroadenoma: morphological observations and a theory of pathogenesis","volume":"29","author":"Koerner","year":"1994","journal-title":"Pathol Annu"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0845","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00000478-199108000-00001","article-title":"Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas","volume":"15","author":"Carney","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0850","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(20010701)92:1<30::AID-CNCR1288>3.0.CO;2-2","article-title":"No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia","volume":"92","author":"Carter","year":"2001","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.151407_bb0855","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.21037\/jtd.2016.10.109","article-title":"Diagnostic performance of core needle biopsy in identifying breast phyllodes tumor","volume":"8","author":"Zhou","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0860","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0.CO;2-6","article-title":"The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases","volume":"77","author":"Reinfuss","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0865","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0960-7404(03)00005-7","article-title":"Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth","volume":"12","author":"Guerrero","year":"2003","journal-title":"Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0870","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1002\/1097-0142(19930515)71:10<3020::AID-CNCR2820711022>3.0.CO;2-G","article-title":"The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast","volume":"71","author":"Bernstein","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0875","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiology.206.1.9423682","article-title":"Lactating adenoma: US features and literature review","volume":"206","author":"Sumkin","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0880","first-page":"232","article-title":"Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations","volume":"5","author":"Grimes","year":"1992","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0885","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/1097-0142(19920101)69:1<141::AID-CNCR2820690125>3.0.CO;2-1","article-title":"The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes","volume":"69","author":"Hawkins","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0890","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1245\/s10434-007-9439-z","article-title":"Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast","volume":"14","author":"Barrio","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0895","doi-asserted-by":"crossref","unstructured":". Koerner FC. Phyllodes tumor. In: Koerner FC, editor. Diagnostic problems in breast pathology. Philadelphia, PA: Saunders, Elsevier; 2009. 329\u2013341.","DOI":"10.1016\/B978-1-4160-2612-9.00018-4"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb0900","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0976-9668.136261","article-title":"Ductal carcinoma in situ in a benign phyllodes tumor of breast: a rare presentation","volume":"5","author":"Ghosh","year":"2014","journal-title":"J Nat Sci Biol Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0905","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/1097-0142(197910)44:4<1305::AID-CNCR2820440421>3.0.CO;2-8","article-title":"Multinucleated mammary stromal giant cells: a benign lesion that simulates invasive carcinoma","volume":"44","author":"Rosen","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0910","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00000478-198611000-00010","article-title":"Mammary fibroadenoma with multinucleated stromal giant cells","volume":"10","author":"Berean","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0915","first-page":"912","article-title":"Multinucleated stromal giant cells in mammary fibroepithelial neoplasms. A study of 11 patients","volume":"118","author":"Powell","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0920","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s004280100470","article-title":"Benign tumors of the breast with multinucleated stromal giant cells. Immunohistochemical analysis of six cases and review of the literature","volume":"439","author":"Ryska","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0925","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1309\/5N2C4N5XCB8XW8JL","article-title":"Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?","volume":"124","author":"Jacobs","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0930","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2559.2010.03607.x","article-title":"Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms","volume":"57","author":"Jara-Lazaro","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0935","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2559.2007.02786.x","article-title":"Histological features useful in the distinction of phyllodes tumor and fibroadenoma on needle croe biopsy of the breast","volume":"51","author":"Lee","year":"2007","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb0940","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00313028709103889","article-title":"Fibroadenomatosis (fibroadenomatoid mastopathy): a benign breast lesion with composite pathologic features","volume":"19","author":"Hanson","year":"1987","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0945","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jcp.55.12.951","article-title":"Hamartoma of the breast: a clinicopathological review","volume":"55","author":"Tse","year":"2002","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.151407_bb0950","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5858\/arpa.2012-0443-RA","article-title":"Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms","volume":"138","author":"Yang","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0955","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1066896910382009","article-title":"CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases","volume":"19","author":"Noronha","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0960","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/jsre.2000.6001","article-title":"CD34, CD117, and actin expression in phyllodes tumor of the breast","volume":"94","author":"Chen","year":"2000","journal-title":"J Surg Res"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0965","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2559.2001.01053.x","article-title":"Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast","volume":"38","author":"Moore","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0970","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jclinpath-2011-200377","article-title":"Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions","volume":"65","author":"Chia","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0975","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/modpathol.2010.141","article-title":"Beta-catenin\/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast","volume":"23","author":"Lacroix-Triki","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0980","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ijc.2910570512","article-title":"Incidence of breast cancer in women with fibroadenoma","volume":"57","author":"Levi","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0985","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C","article-title":"Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group","volume":"69","author":"McDivitt","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb0990","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/oxfordjournals.aje.a116341","article-title":"Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up","volume":"135","author":"Krieger","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.151407_bb0995","article-title":"Transformation of benign fibroadenoma to malignant phyllodes tumor","volume":"4","author":"Sanders","year":"2015","journal-title":"Acta Radiol Open"},{"issue":"18","key":"10.1016\/j.anndiagpath.2019.151407_bb1000","first-page":"2495","article-title":"First case of transformation for breast fibroadenoma to high-grade malignant phyllodes tumor in an in vitro fertilization patient: misdiagnosis of recurrence, treatment and review of the literature","volume":"17","author":"Pacchiarotti","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151407_bb1005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12282-009-0185-x","article-title":"Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors","volume":"18","author":"Abe","year":"2011","journal-title":"Breast Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb1010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jso.20334","article-title":"Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases","volume":"91","author":"Chen","year":"2005","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151407_bb1015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amjsurg.2016.12.017","article-title":"Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors","volume":"214","author":"Marcil","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb1020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1524-4741.2010.01013.x","article-title":"Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast","volume":"16","author":"Resetkova","year":"2010","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb1025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamasurg.2014.73","article-title":"Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor","volume":"149","author":"Van Osdol","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb1030","first-page":"27","article-title":"Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy","volume":"20","author":"Wiratkapun","year":"2014","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb1035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCPZUZ96RESGPUP","article-title":"Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens","volume":"142","author":"Yasir","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2019.151407_bb1040","series-title":"Version 1.2016","article-title":"NCCN clinical practice guidelines in oncology: Breast cancer","year":"2016"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151407_bb1045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/tbj.12727","article-title":"How wide should margins be for phyllodes tumors of the breast?","volume":"23","author":"Tremblay-LeMay","year":"2017","journal-title":"Breast J"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.151407_bb1050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jjco\/hym099","article-title":"Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin","volume":"37","author":"Taira","year":"2007","journal-title":"Jpn J Clin Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419302096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419302096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:20Z","timestamp":1761078680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913419302096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":210,"alternative-id":["S1092913419302096"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151407","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Core needle biopsy of benign, borderline and in-situ problematic lesions of the breast: Diagnosis, differential diagnosis and immunohistochemistry","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151407"}}